Biogen Aktie
124,60
EUR
-4,95
EUR
-3,82
%
135,40
USD
-3,06
USD
-2,21
%
Werbung
Biogen Aktie Analyse
| 09.09.05 | Biogen market perform | Piper Jaffray | |
| 28.07.05 | Biogen equal-weight | Morgan Stanley | |
| 17.06.05 | Biogen in-line | Goldman Sachs | |
| 10.06.05 | Biogen market perform | Piper Jaffray | |
| 09.06.05 | Biogen in-line | Goldman Sachs | |
| 03.06.05 | Biogen equal-weight | Morgan Stanley | |
| 03.06.05 | Biogen Equal-weight | Morgan Stanley | |
| 03.06.05 | Biogen neutral | UBS | |
|
Werbung
|
|||
| 01.06.05 | Biogen neutral | Prudential Financial | |
| 01.06.05 | Biogen neutral-weight | Prudential Financial | |
| 28.04.05 | Biogen Hold | Deutsche Securities | |
| 15.04.05 | Biogen Sector Perform | RBC Capital Markets | |
| 01.03.05 | Biogen Hold | AG Edwards | |
| 01.03.05 | Biogen Neutral | Prudential Securities | |
| 01.03.05 | Biogen Hold | Lazard Freres | |
| 01.03.05 | Biogen Market Perform | U.S. Bancorp Piper Jaffray | |
| 01.03.05 | Biogen Equal weight | Lehman Brothers | |
| 28.02.05 | Biogen Neutral | Credit Suisse First Boston | |
| 28.02.05 | Biogen Neutral | JP Morgan | |
| 28.02.05 | Biogen Sector Perform | CIBC World Markets | |
Werbung
Werbung